Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments

INTRODUCTION: Among the most pressing clinical decisions in type 2 diabetes treatments are which drugs should be used after metformin is no longer sufficient, and whether sulfonylureas (SUs) should remain as a suitable second-line treatment. In this article we summarize current evidence on the long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, W. Ryan, Christiansen, Cindy L., Miller, Donald R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064594/
https://www.ncbi.nlm.nih.gov/pubmed/29808360
http://dx.doi.org/10.1007/s13300-018-0443-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064594/
https://www.ncbi.nlm.nih.gov/pubmed/29808360
http://dx.doi.org/10.1007/s13300-018-0443-z

Ejemplares similares